217 reports of this reaction
1.6% of all TRANEXAMIC ACID reports
#13 most reported adverse reaction
ANAPHYLACTIC REACTION is the #13 most commonly reported adverse reaction for TRANEXAMIC ACID, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 217 FDA adverse event reports linking TRANEXAMIC ACID to ANAPHYLACTIC REACTION. This represents approximately 1.6% of all 13,960 adverse event reports for this drug.
Patients taking TRANEXAMIC ACID who experience anaphylactic reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAPHYLACTIC REACTION is a less commonly reported adverse event for TRANEXAMIC ACID, but still significant enough to appear in the safety profile.
In addition to anaphylactic reaction, the following adverse reactions have been reported for TRANEXAMIC ACID:
The following drugs have also been linked to anaphylactic reaction in FDA adverse event reports:
ANAPHYLACTIC REACTION has been reported as an adverse event in 217 FDA reports for TRANEXAMIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAPHYLACTIC REACTION accounts for approximately 1.6% of all adverse event reports for TRANEXAMIC ACID, making it a notable side effect.
If you experience anaphylactic reaction while taking TRANEXAMIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.